Market revenue in 2022 | USD 27.0 million |
Market revenue in 2030 | USD 71.0 million |
Growth rate | 12.8% (CAGR from 2022 to 2030) |
Largest segment | Medical writing & publishing |
Fastest growing segment | Medical Science Liaisons (MSLs) |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons (MSLs), Medical Information |
Key market players worldwide | IQVIA Holdings Inc, Icon PLC, The Medical Affairs Company, Syneos Health, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, SGS AG, Ashfield Healthcare, ZEINCRO Group, Indegene |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical affairs outsourcing market will help companies and investors design strategic landscapes.
Medical writing & publishing was the largest segment with a revenue share of 36.67% in 2022. Horizon Databook has segmented the UAE medical affairs outsourcing market based on medical writing & publishing, medical monitoring, medical science liaisons (msls), medical information covering the revenue growth of each sub-segment from 2018 to 2030.
Currently, UAE is the third largest market for regulatory affairs outsourcing in the MEA region since most market players are dependent on imports. Medical device regulations in the country are based on Australian TGA, EU, and the U.S. regulations. Products with approval from the Canadian, Australian, EU, and the U.S. regulatory agencies are eligible for a short registration process in the UAE.
The UAE Government is focused on attracting innovative drug manufacturers by 2021, with double the number of local companies producing patented drugs. The country has a short drug registration system for both innovator and generic drugs approved by the U.S. FDA. Some of the examples of fast-tracked drugs in UAE are AbbVie’s Viekirax, Exviera (dasabuvir), and Eli Lilly's Trulicity.
Leading multinationals in the country include Sanofi, Novartis, Amgen, Pfizer, and GSK. Increase in the number of local and foreign players manufacturing innovator drugs will indirectly boost demand for medical affair services.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE medical affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into UAE medical affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account